BGT vs IMM

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

55MEDIUM

IMM

IMMUTEP FPO [IMM]

56MEDIUM

Score Breakdown

BGT IMM
Technical
62
38
Catalyst
51
64
Sentiment
50
50
Fundamental
41
90
Momentum
80
58
Risk Gate
34
42

Key Metrics

BGT Metric IMM
$10.7MMarket Cap$69.3M
126KAvg Volume (20d)49.9M
N/AShort Interest+0.6%
$0.06152-Week High$0.470
$0.01652-Week Low$0.028
+0.0%Daily Change-2.2%
$0.035Entry Price$0.045
-202.2%ROE-61.8%
N/AProfit MarginN/A

Active Signals

BGT Signals

●Stochastic is deep in oversold territory — bounce conditions forming
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (1.7 quarters)
●Strong revenue growth (+208%)
●Micro-cap ($5-20M) - high risk
●CANSLIM S: Tight float (35%)
●Not enough chatter to gauge sentiment — defaulting to neutral
●Sentiment is mixed — no strong consensus either way

IMM Signals

●RSI is looking oversold — historically a spot where stocks tend to bounce
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Volume surging at 10.5x normal while price falls — heavy selling pressure
●Took a hit — down 11.8% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (6 quarters)
●Moderate P/S ratio (8.7x)

Ask Scout AI to compare BGT and IMM in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
BGT Full Analysis → IMM Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).